Kronos Bio
KRON
KRON was delisted on the 20th of June, 2025.
83 hedge funds and large institutions have $812M invested in Kronos Bio in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 7 closing their positions.
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
32% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 19
8% more funds holding
Funds holding: 77 → 83 (+6)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2.27% less ownership
Funds ownership: 71.11% → 68.84% (-2.3%)
15% less capital invested
Capital invested by funds: $956M → $812M (-$145M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.02M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.47M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$5.45M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$3.56M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$2.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$40.7M |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$6.01M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.52M |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$3.5M |
| 5 |
PA
Perceptive Advisors
New York
|
-$2.3M |
KRON Hedge Fund Activity: Q3 2021 in Review
83 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q3 2021, worth a combined $812M — down 15% from $956M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new KRON positions and 7 closed out — a net gain of 7 holders — while 25 added to existing stakes and 19 trimmed.
The largest buyer was Vanguard Group, adding an estimated $8.02M. The largest seller was Capital Research Global Investors, cutting an estimated $40.7M.
- 83 institutional investors held Kronos Bio (KRON) as of Q3 2021, up from 77 in Q2 2021.
- Funds reported $812M of Kronos Bio stock for Q3 2021, down 15% quarter-over-quarter.
- 14 funds opened new Kronos Bio positions in Q3 2021 and 7 closed out, a net change of +7 holders.
- The largest Kronos Bio buyer in Q3 2021 was Vanguard Group, an estimated $8.02M added.
- The largest Kronos Bio seller in Q3 2021 was Capital Research Global Investors, an estimated $40.7M sold.
Based on aggregated 13F filings for Q3 2021.